Sicart Associates Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
|
+$13.6M |
| 2 |
Intel
INTC
|
+$4.99M |
| 3 |
WBA
Walgreens Boots Alliance
WBA
|
+$4.96M |
| 4 |
SLB Ltd
SLB
|
+$3.45M |
| 5 |
Cars.com
CARS
|
+$1.62M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.59M |
| 2 |
GG
Goldcorp Inc
GG
|
+$1.27M |
| 3 |
SPDR Gold Trust
GLD
|
+$1.26M |
| 4 |
Colgate-Palmolive
CL
|
+$836K |
| 5 |
Corning
GLW
|
+$678K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.86% |
| 2 | Energy | 16.26% |
| 3 | Technology | 13.56% |
| 4 | Consumer Staples | 9.11% |
| 5 | Communication Services | 8.15% |
Similar funds
Sicart Associates's Q2 2019 Portfolio in Review
As of Q2 2019, Sicart Associates held 84 positions worth $246M, up 4% from $237M the previous quarter. Its ten largest holdings account for 52% of the portfolio.
Sicart Associates deployed $20.6M of net new capital in Q2 2019, opening 6 new positions and adding to 12 existing holdings. Its largest new stake was iPath Series B S&P 500 VIX Short-Term Futures ETN: 7,678 shares worth $12.8M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 22% a quarter earlier, followed by Energy and Technology.
On the sell side, the largest reduction was SPDR Gold Trust, an estimated $1.26M trimmed.
- Sicart Associates's largest Q2 2019 buy was iPath Series B S&P 500 VIX Short-Term Futures ETN: 7,678 shares worth $12.8M.
- Sicart Associates added most to Intel in Q2 2019, an estimated $4.99M increase.
- Sicart Associates's biggest Q2 2019 reduction was SPDR Gold Trust, cutting an estimated $1.26M.
- Sicart Associates fully exited Microsoft in Q2 2019, selling an estimated $1.59M.
- Sicart Associates's ten largest holdings make up 52% of its $246M portfolio in Q2 2019.
- Sicart Associates opened 6 new positions and closed 6 in Q2 2019.
- Sicart Associates's portfolio value rose 4% quarter-over-quarter to $246M.
Based on Sicart Associates's 13F filing for Q2 2019, filed 23 Jul 2019.